Tengion Overview
- Founded
-
2003

- Status
-
Public
- Employees
-
40

- Stock Symbol
-
TNGNQ

Tengion General Information
Description
Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace damaged tissue or organ. Its product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. The company's solution Neo-Kidney Augment is based on its proprietary technology, which uses tubular epithelial cells, procured by a cortical biopsy of the patient's kidney, to create an injectable product candidate that can catalyze the regeneration of functional kidney tissue.
Contact Information
- 3929 Westpoint Boulevard
- Suite G
- Winston-Salem, NC 27103
- United States
Tengion Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
34.5K |
Tengion Financials Summary
In Thousands, USD |
TTM 30-Sep-2014 | FY 2013 31-Dec-2013 | FY 2012 31-Dec-2012 | FY 2011 31-Dec-2011 |
---|---|---|---|---|
EV | 21,804 | 2,588 | 6,175 | (2,938) |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (56,419) | (11,085) | (13,543) | (15,124) |
Net Income | (64,426) | (18,927) | (16,929) | (19,061) |
Total Assets | 9,621 | 25,724 | 12,435 | 17,817 |
Total Debt | 34,122 | 26,952 | 11,269 | 4,987 |
Tengion Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Tengion Comparisons
Industry
Financing
Details
Tengion Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Mimedx | Corporation | Marietta, GA | 000 | 00000 | 000000000 | 00000 |
0000000000000 0000 | Corporation | Rancho Cordova, CA | 00 | 000.00 | 00000000 | 000.00 |
Tengion Patents
Tengion Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2011224448-A1 | Cell-scaffold constructs | Inactive | 09-Mar-2010 | 00000000000 | |
US-20110224800-A1 | Cell-scaffold constructs | Inactive | 09-Mar-2010 | 00000000000 | 00 |
CA-2791736-A1 | Cell-scaffold constructs | Inactive | 09-Mar-2010 | 00000000000 | |
EP-2544726-A1 | Cell-scaffold constructs | Inactive | 09-Mar-2010 | 00000000000 | |
US-20110123455-A1 | Rational design of regenerative medicine products | Inactive | 12-Nov-2009 | G01N33/5088 |
Tengion Executive Team (11)
Tengion Board Members (10)
Name | Representing | Role | Since |
---|---|---|---|
0000-00000 0000000 | Self | Board Member | 000 0000 |
00000 000000 | Tengion | Chairman & Board Member | 000 0000 |
00000 00000000 00 | Self | Board Member | 000 0000 |
0000 000000 | Tengion | Chief Executive Officer & Board Member | 000 0000 |
00000 0000000 | Self | Board Member | 000 0000 |